Fundraising FoxAxithra
8 known investors
Find your way into Axithra
Sign up to see every warm intro you have to Axithra
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Axithra team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Axithra, a spin-off from Ghent University's Photonics Research Group and imec, develops an optics- and photonics-based platform for therapeutic drug monitoring that measures and monitors drug concentrations in blood at the point of care. Its lead application targets personalizing β-lactam antibiotic treatment for patients in intensive care units.
Investors · 8
How we know: imec.xpand's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Kurma Partners's portfolio page · a partner's Signal profile · funding news · siliconsemiconductor.net · the VCSheet dataset · Not right? Tell us
How we know: Qbic Fund's portfolio page · siliconsemiconductor.net · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements- Undisclosed amountseed roundSep 2023
imec.xpand (lead), Kurma Partners (lead), Hamamatsu Photonics, Noshaq, Qbic, Wallonie Entreprendre, Werfen Diagnostics, White Fund
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Axithra do?
- Axithra, a spin-off from Ghent University's Photonics Research Group and imec, develops an optics- and photonics-based platform for therapeutic drug monitoring that measures and monitors drug concentrations in blood at the point of care. Its lead application targets personalizing β-lactam antibiotic treatment for patients in intensive care units.
- Who are Axithra's investors?
- Axithra's investors include imec.xpand, Kurma Partners, Qbic Fund, White Fund, Wallonie Entreprendre.